Bias refers to a systematic distortion by which an estimated effect in clinical trials can deviate from the treatment effect of interest. Unlike random variation, bias is not eliminated solely by a larger sample size. It can arise from planning, selection of participants, conduct, data collection, analysis or reporting and impair the credibility of both efficacy and safety findings.<\/p>\n
A trial can be precise but systematically distorted. A narrow confidence interval only indicates that the estimated value was determined relatively precisely under the used data and assumptions; it does not prove that the comparison groups were compared fairly. Random error is described in statistics via variation and confidence intervals. Bias, on the other hand, affects the direction or magnitude of the estimate and must be limited through an appropriate design and controlled processes.<\/p>\n
The risks are not limited to a single trial phase. Unclear endpoint definitions, differences in concomitant care, incomplete follow-up or retrospective changes to the analysis can each influence the conclusion on a treatment effect. ICH E8(R1) therefore requires critical quality factors to be identified already during planning and the design to be aligned towards a reliable answering of the research question.<\/p>\n
Selection bias can arise if the groups differ in prognostically important characteristics before the start of treatment or if the assignment is predictable. Performance bias is possible if groups receive different care apart from the investigational intervention. Detection or assessment bias threatens if the knowledge of the treatment influences the measurement or evaluation of an endpoint. Missing data can cause further distortion, especially if their occurrence is related to treatment and outcome.<\/p>\n
Analysis and reporting decisions can also facilitate bias. If only favorable subgroups, endpoints or time points are highlighted, no robust confirmatory evidence is generated. Pre-specified objectives, endpoints, analysis populations and methods reduce the room for discretion after knowledge of the results. Sensitivity analyses check whether central conclusions hold up under plausible alternative assumptions.<\/p>\n
Randomization with concealed allocation is an essential measure against selection bias. Blinding can reduce differences in care, endpoint collection and assessment, if it is practically and ethically possible. Uniform training, clear working instructions, centrally defined endpoints and risk-based monitoring support a comparable conduct. The chosen measures must be appropriate to the risk for participants and the importance of the data.<\/p>\n
According to ICH E6(R3), criteria for analysis sets, the handling of missing or erroneous data and relevant changes are to be traceably documented. In this context, data quality does not mean maximum data collection, but reliable data that are essential for the trial objectives. In case of anomalies, it is not sufficient merely to correct individual data points; possible causes and consequences for the interpretation must also be assessed.<\/p>\n
Immortal time bias is a specific time-related distortion in observational analyses. It arises if a period of time during which an event cannot occur by definition is attributed to the exposed group or if exposure and start of observation are not aligned equally. It is therefore neither merely a selection error nor a recall error and is not resolved solely by general quality controls.<\/p>\n
Appropriate countermeasures are a precise time-dependent definition of exposure, a consistent start of observation as well as, if applicable, time-dependent models or landmark analyses. The general term bias remains broader: it encompasses systematic distortions in different trial types and phases. In randomized confirmatory trials, the focus is particularly on randomization, blinding, endpoint quality and the handling of missing data.<\/p>\n
Bias can generate a positive conclusion in favor of the investigational intervention or obscure an actual difference. Transparent pre-specifications and a traceable conduct are therefore important for confirmatory trials. Authorities and auditors assess whether the data are suitable to answer the objective and whether deviations, missing data or unblinding could impair the comparability of the groups.<\/p>\n
Full-service CROs such as Mediconomics support with risk-based trial planning, the preparation of protocol and statistical analysis plan, the training of investigational sites as well as with monitoring and data management. They document quality-relevant deviations, coordinate data reviews and prepare the presentation of methods, deviations and sensitivity analyses for the clinical study report.<\/p>\n
Is bias the same as an imprecise estimate?<\/strong><\/p>\n No. Imprecision describes random variation; bias is a systematic deviation that can persist even with many participants.<\/p>\n Does randomization eliminate every bias?<\/strong><\/p>\n It primarily reduces selection bias and distributes both known and unknown prognostic factors on average. Problems with blinding, data collection or follow-up can nevertheless remain.<\/p>\n Are missing data always a bias?<\/strong><\/p>\n No, but they can lead to bias. Crucial is why data are missing and whether this is related to treatment or unobserved outcome.<\/p>\n Bias refers to a systematic distortion by which an estimated effect in clinical trials can deviate from the treatment effect of interest. Unlike random variation, bias is not eliminated solely by a larger sample size. It can arise from planning, selection of participants, conduct, data collection, analysis or reporting and impair the credibility of both […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[],"class_list":["post-6590","glossary","type-glossary","status-publish","hentry"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":1,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6590\/revisions"}],"predecessor-version":[{"id":7501,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6590\/revisions\/7501"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=6590"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=6590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory references<\/h2>\n
\n